These compounds may interact with:
Protein DBF4 homolog A
Potentially involved in: adrenocortical carcinoma; adult high grade glioma; astrocytoma; colon cancer; ductal carcinoma in situ; esophageal adenocarcinoma; glioblastoma; group 3 medulloblastoma; intraductal papillary-mucinous carcinoma (ipmc); intraductal papillary-mucinous neoplasm (ipmn); invasive ductal carcinoma; lung cancer; malignant mesothelioma; medulloblastoma, large-cell; multiple myeloma; nasopharyngeal carcinoma; non-small cell lung cancer; oligodendroglioma; ovarian cancer; primary sjogren syndrome
Disease data sourced from Pharos.